Results 61 to 70 of about 52,218 (248)

Tamper‐Responsive Physical Unclonable Functions via Graphene‐Interlayered Block Copolymer Random Structures

Advanced Materials, EarlyView.
Self‐invalidating multilayer physical unclonable functions (PUFs) integrate fingerprint‐like metal nanopattern bilayers from block copolymer templates with highly reactive reduced graphene oxide (rGO) interlayers. This tamper‐responsive architecture blocks all unauthorized physical and chemical replication attempts while autonomously deactivating ...
Gyu Hui Jo, Dae Hui Park, Jeong‐Ho Jang, Woo Seok Tack, Jin Man Kim, Hak Ki Yu, Hyeong Min Jin, Jang Hwan Kim   +7 more
wiley   +1 more source

Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome

Frontiers in Immunology
IntroductionAnti-SSA antibodies target two unrelated proteins, Ro52 (E3 ligase) and Ro60 (RNA binding protein). Previous studies indicate that anti-Ro52 antibodies are frequently associated with various myositis-specific autoantibodies (MSAs)–including ...
Koichi Yamaguchi, Koichi Yamaguchi, Qi Tang, Qi Tang, Paul Poland, Daniel P. Reay, Alyssa Gregory, Rohit Aggarwal, Chester V. Oddis, Dana P. Ascherman   +9 more
doaj   +1 more source

Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?

Frontiers in Neurology, 2019
Dysphagia can be predominant or sole symptom of myositis. However, diagnostic evaluation is difficult in such cases. Here, we present evidence for dysphagia as sole manifestation of Jo-1 associated myositis.
Bendix Labeit, Paul Muhle, Sonja Suntrup-Krueger, Sigrid Ahring, Tobias Ruck, Rainer Dziewas, Tobias Warnecke   +6 more
doaj   +1 more source

Reply: Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1 [PDF]

Brain, 2016
Sir, In their letter Uruha et al. (2016) report on their analysis of an important number of muscle samples from patients with non-Jo-1 anti-synthetase antibodies to determine if the pattern of ‘perifascicular necrotizing myositis’ that we previously described in patients with anti-Jo-1 antibodies is also observed.
Yves, Allenbach, Baptise, Hervier, Werner, Stenzel, Olivier, Benveniste   +3 more
openaire   +2 more sources

Charge‐Reversed Lipid Nanoparticles Enable Encapsulation of Pt2L4 Nanocages for In vivo Anti‐Cancer Treatment

Advanced Materials, EarlyView.
Charge‐reversed lipid nanoparticles (revLNPs) enable efficient encapsulation and delivery of cationic Pt2L4 nanocages. Encapsulation preserves potent anticancer activity while improving circulation, reducing vascular leakage, and promoting favorable biodistribution in vivo.
Renzo A. Knol, Bochuan Hu, Eduard O. Bobylev, Martina Farber, Petrus C. M. Laan, Thomas J. F. Kock, Bauke Fontein, Johanna Erbani, Oscar Escalona‐Rayo, Seline S. Roose, Tom Keijer, Gabriel Forn‐Cuní, B. Ewa Snaar‐Jagalska, Leila Akkari, Joost N. H. Reek, Alexander Kros, Dennis Aschmann   +16 more
wiley   +1 more source

Anti-Jo-1 antisynthetase syndrome.

Revista brasileira de reumatologia, 2011
Given a lack of population-based studies, we report an epidemiological-clinic study of anti-Jo-1 antisynthetase syndrome (ASS).To study a retrospective cohort of a single-center from 1980 to 2010. Clinical-laboratory and demographic data were obtained from medical files. All patients fulfilled the Bohan and Peter criteria (1975) and presented anti-Jo-1,
Samuel Katsuyuki, Shinjo, Mauricio, Levy-Neto   +1 more
openaire   +1 more source

Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies [PDF]

European Respiratory Journal, 1997
Interstitial lung disease (ILD) is a complication of polymyositis (PM) and dermatomyositis (DM). It often manifests itself in association with myositis-specific antisynthetase autoantibodies, among which anti-Jo-1 antibodies are the most commonly encountered.
Sauty, A., Rochat, T., Schoch, O. D., Hamacher, J., Kurt, A. M., Dayer, J. M., Nicod, L. P.   +6 more
openaire   +4 more sources

Synthesis of Ti2B2Clx MBenes in Molten Salts From Theoretical and Experimental Perspectives

Advanced Materials, EarlyView.
By integrating a theoretical framework with experiments, Ti2InB2 was selectively etched with ZnCl2 to produce a multilayer (ml) Ti2B2Clx MBene. The In atoms are completely removed, with simultaneous incorporation of chlorine surface terminations. in situ x‐ray diffraction indicates a direct biphasic transformation from Ti2InB2 to ml‐MBene, with no ...
Rodrigo M. Ronchi, Emile Defoy, Andrejs Petruhins, Justinas Palisaitis, Leiqiang Qin, Joseph Halim, Lianghao Yu, Lan Tang, Solenn Reguer, Dominique Thiaudière, Ningjun Chen, Durga Sankar Vavilapalli, David Portehault, Jonas Björk, Per O. Å. Persson, Johanna Rosen   +15 more
wiley   +1 more source

Anti-Jo-1 antibody positive polymyositis—successful therapy with leflunomide

Autoimmunity, 2006
Idiopathic inflammatory myopathies (IM), including dermatomyositis (DM) and polymyositis (PM), are a group of systemic rheumatologic diseases of unknown etiology characterized by chronic myositis. Antisynthetase antibodies such as the anti-Jo-1 antibody are known to be highly specific for inflammatory myopathies.
Uwe, Lange, Manfred, Piegsa, Ulf, Müller-Ladner, Johannes, Strunk   +3 more
openaire   +2 more sources

Defined Matrices Reveal Epithelial‐ and Mesenchymal‐Specific Responses to Stiffness and Adhesion in Human iPSC‐Derived Intestinal Organoids

Advanced Materials, EarlyView.
Defined PEG hydrogels enable human iPSC‐derived intestinal organoid culture without Matrigel. PEG‐ and Matrigel‐cultured organoids both support duodenal‐like epithelial identity, but direct comparison reveals subtle epithelial differentiation‐marker shifts and stronger mesenchymal ECM‐remodeling/integrin programs in PEG.
Alicja Kuziola, Tamara Fawzi, Emma H. Kromann, Marion Leleu, Joanna M. Drelinkiewicz, Dusko Ilic, Cécile A. Dreiss, Joana F. Neves, Eileen Gentleman   +8 more
wiley   +1 more source